FIELD: medicine, pharmaceutics.
SUBSTANCE: tricyclic compounds of formula I: 
$ substituted with heterocycle are disclosed, or pharmaceutically acceptable salt or solvate of specified compound, isomer or racemic mixture, where 
stands for optional double link, dotted line stands for link or does not stand for link, which results in double or single link according to requirements of valency and where A, B, G, M, X, J, n, Het, R3, R10, R11, R32 and R33 and other substituents are such as indicated in formula of invention. Invention also relates to pharmaceutical compositions, which contain them, method of thrombin receptor or cannabinoid receptor inhibition, and to method for treatment of disease related to thrombosis, atherosclerosis, restenosis, hypertension, stenocardia, arrhythmia, cardiac failure and cancer by administration of specified compounds.
EFFECT: production of compounds having properties of antagonists of thrombin receptors.
33 cl, 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLO[2,3-b]PYRIDINE DERIVATIVES INHIBITING ACTIVITY OF ANTI-APOPTOTIC Bcl-2 PROTEINS | 2011 |
|
RU2567857C2 |
| TRICYCLIC ANTAGONISTS OF THROMBIN RECEPTORS | 2003 |
|
RU2329264C9 |
| PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
| TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677698C1 |
| IMIDAZOTHIAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2683940C1 |
| IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, SYNTHESIS THEREOF AND METHODS OF USING SAME | 2010 |
|
RU2608611C2 |
| PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
